<DOC>
	<DOCNO>NCT00955097</DOCNO>
	<brief_summary>The primary purpose study demonstrate safety effectiveness use intra-operative ultrasound contrast agent ( Definity® ) identification know liver tumor .</brief_summary>
	<brief_title>Evaluation Intra-operative Ultrasound Contrast Enhancement Evaluation Liver Tumors</brief_title>
	<detailed_description>The primary objective study demonstrate safety use intra-operative ultrasound contrast ( Definity® ) administration . The secondary objective study demonstrate improve image quality conspicuity know liver tumor use contrast enhancement .</detailed_description>
	<mesh_term>Liver Neoplasms</mesh_term>
	<criteria>1 . Undergoing hepatic resection hepatic ablation preoperative visualize liver tumor : 2 . ≥ 18 year age 3 . If female childbearing potential , negative pregnancy test within 14 day prior surgery 4 . If subject sexually active male sexually active female childbearing potential , subject agrees use medically accept form contraception time enrollment completion followup study visit . 5 . IRBapproved informed consent , sign subject subject 's legally authorize representative . ≥ 18 year age 1 . Not suitable candidate operation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Definity</keyword>
	<keyword>liver tumor</keyword>
	<keyword>intra operative contrast</keyword>
	<keyword>liver cancer</keyword>
	<keyword>hepatic tumor</keyword>
	<keyword>identify liver tumor</keyword>
	<keyword>surgery liver tumor</keyword>
	<keyword>Patients know hepatic tumor</keyword>
</DOC>